Top

Published in:

01-02-2008 | Case Report

Cytomegalovirus infection in a patient with atypical Kawasaki disease

Authors: Belgin Usta Guc, Nurcan Cengiz, Selman Vefa Yildirim, Yasemin Uslu

Published in: Rheumatology International | Issue 4/2008

Abstract

Kawasaki disease (KD) is an acute, febrile, and multisystem vasculitis of early childhood with a striking predilection for the coronary arteries. The most significant complication is coronary artery abnormalities, including coronary aneurysms. The etiology of KD remains unknown. Many infectious agents including viruses have been postulated as possible causes of KD. But standard microbiologic techniques, molecular methods and serologic investigations have failed to identify an etiologic agent. We described a patient with atypical KD during cytomegalovirus infection.

Burgner D, Harnden A (2005) Kawasaki disease: what is the epidemiology telling us about the etiology? Int J Infect Dis 9(4):185–194PubMedCrossRef

Royle J, Burgner D, Curtis N (2005) The diagnosis and management of Kawasaki Disease. J Paediatr Child Health 41(3):87–93PubMedCrossRef

Rowley AH, Goonzalez-Crussi F, Gidding SS, Duffy CE, Shulman ST (1987) Incomplete Kawasaki disease with coronary artery involvement. J Pediatr 110:409–413PubMedCrossRef

Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML, Kahn JS (2005) Association between a novel human coronavirus and Kawasaki Disease. J Infect Dis 191(4):499–502PubMedCrossRef

Meyer MF, Hellmich B, Kotterba S, Schatz H (2000) Cytomegalovirus infection in systemic necrotizing vasculitis: causative agent or opportunistic infection? Rheumatol Int 20(1):35–38PubMedCrossRef

Pass RF (2002) Cytomegalovirus infection. Pediatr Rev 23(5):163–170PubMedCrossRef

Aarnisalo J, Ilonen J, Vainionpaa R, Volanen I, Kaitosaari T, Simell O (2003) Development of antibodies against cytomegalovirus, varicella-zoster virus and herpes simplex virus in Finland during the first eight years of life: A prospective study. Scand J Infect Dis 35:750–753PubMedCrossRef

Tatum ET, Sun PC, Cohn DL (1989) Cytomegalovirus vasculitis and colon perforation in a patient with the acquired immunodeficiency syndrome. Pathology 21(4):235–238PubMedCrossRef

Lanari M, Lazzarotto T, Papa I, Venturi V, Bronzetti G, Guerra B, Faldella G, Corvaglia L, Picchio FM, Landini MP, Salvioli GP (2001) Neonatal aortic arch thrombosis as a result of congenital cytomegalovirus infection. Pediatrics 108(6):114CrossRef

10.

Lozinguez O, Arnaud E, Velut JG, Tiev KP, Fiessinger JN, Emmerich J (1999) Cytomegalovirus and arterial disease: current aspects. Arch Mal Coeur Vaiss 92(9):1205–1212PubMed

11.

Presti MP, Pollock JL, Dal Canto AJ, O’Guin AK, Virgin IV HW (1998) Interferon γ regulates acute and latent Murine Cytomegalovirus infection and chronic disease of the great vessels. J Exp Med 188(3):577–588PubMedCrossRef

12.

Ghigliotti G, Canessa A, Pastorino A, Mazzarello G, De Marchi R, Gambini C (1994) Necrotizing vasculitis induced by CMV in a woman with acquied immunodeficiency syndrome. Ann Dermatol Venereol 121:820–822PubMed

13.

Doherty M, Bradfield JWB (1981) Polyarteritis nodosa associated with acute cytomegalovirus infection. Ann Rheum Dis 40:419–421PubMedCrossRef

14.

Charlotte CP, Pierre Q, Marianne LV, Florentia K, Dominique G, Gérard L (2005) Primary cytomegalovirus infection, atypical Kawasaki Disease, and coronary aneurysms in 2 infants. Clin Infect Dis 41:53–56CrossRef

Title: Cytomegalovirus infection in a patient with atypical Kawasaki disease
Authors: Belgin Usta Guc
Nurcan Cengiz
Selman Vefa Yildirim
Yasemin Uslu
Publication date: 01-02-2008
Publisher: Springer-Verlag
Published in: Rheumatology International / Issue 4/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-007-0440-4

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Cytomegalovirus infection in a patient with atypical Kawasaki disease

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2008

Pathogenesis-related adhesion molecules in Henoch–Schonlein vasculitis

Chylothorax and chylopericardium as the initial clinical manifestation of Behcet’s disease

Two cases of eosinophilic vasculitis with thrombosis

AA amyloidosis associated with systemic lupus erythematosus: impact on clinical course and outcome

Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis

Assessment of endothelial function in complex regional pain syndrome type I

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page